ValamAi aims to create substantial long-term value by bringing new, differentiated RNA therapies to patients. As we advance our platform and pipeline toward the clinic, we welcome conversations with strategic and financial partners who share that mission.

Investor and supporter details will be listed here as they are finalized. If you are an investor interested in ValamAi, please get in touch.